University of Kentucky Research

•James Anderson, Internal Medicine, Clinical Trial, A Randomized, Double-Blind, Pacebo-Controlled, Multicenter, Parallel-Group Study to Assess the Efficacy and Safety of Topiramate OROS Controlled-Release in the Treatment of Obese, Type 2 Diabetic Subjects Managed with Diet or Metformin.
•James Anderson, Internal Medicine, Clinical Trial, Phase 2, Multicenter, Randomized, Blinded, Placebo Controlled, Proof of Concept Study of Combination Therapy for Safety and Efficacy in Subjects with Uncomplicated Obesity.
•Andre Baron, Cancer Center-Core Support, $100,000, Evaluating Low Dose Computed Tomography and The Serum Biomarkers for Lung Cancer Screening.
•Crystal Collins-Camargo, Social Work, $115,000, FRIENDS.
•Mark Dignan, Kentucky Community Cancer Program, $241,144, Network Site, Cancer Prevention and Control Network (WVU SIP #2).
•Paul Eakin, Mathematics, $420,375, Appalachian Mathematics and Science Partnership.
•Paul Eakin, Mathematics, $6,973, Appalachian Mathematics and Science Partnership.
•Ahmed El-Ghannam, Graduate Center for Biomedical Engineering, $15,000, KSEF: Innovative Delivery System for BMP-2 to Treat Segmental Bone Defect.
•Toufic Fakhoury, Neurology, Clinical Trial, LAM40124 An Assesment of Behavioral Changes Associated with Lamotrigine and Levetiracetam in Patients with Epilepsy.
•James Ferguson II, Obstetrics and Gynecology, $48,543, Ferguson Scope Effects of Periodontal Therapy on Preterm Birth.
•C. Frost, Law Instruction, $18,000, Legal Assistance to Inmates.
•Phillip Gerk, Toxicology, $20,000, In vitro mechanisms of action of ursodeoxycholic acid.
•Richard Greenberg, Internal Medicine, Clinical Trial, The Safety, Tolerability, and Immunogenicity of ACAM2000 Smallpox Vacine in Adults with Previous Smallpox Vaccination. A Randomized, Double-Blind, Fixed Dose, Phase 3 Comparison between ACAM2000 and Dryvax Smallpox Vaccines.
•Eric Grulke, Chemical and Materials Engineering, $73,061, Heat Transfer Mechanisms for Nanofluids in Laminar Flow.
•Edward Hall, Spinal Cord and Brain Injury Research Center, $340,342, Peroxynitrite-Induced Oxidative Damage in TBI NIH/NINDS.
•Charles Knapp, Center for Biomedical Engineering, $24,000, Prototype of an Adjustable Systemic Pulmonary Arterial Shunt.
•Carl Leukefeld, Center on Drug and Alcohol Research, $349,358, Prescription Drug Study.
•Nancy Levenson, Physics and Astronomy, $61,330, Probing Obscured AGN with X-ray Iron Lines.
•Kevin Pearce, Family Practice and Community Medicine, $106,830, Restricted Scope for Faculty Development in Primary Care.
•Robert Perry, Microbiology, Immunology and Molecular Genetics, $123,574, Attenuated Live and Recombinant Yersinia Pestis Vaccines.
•Holly Salisbury, Center for the Arts Service Center, $1,000, Meet the Composer Grant.
•M. Smith, CES/Director’s Office, $250,000, The Kentucky Natural Products Alliance.
•Suzanne Smith, Mechanical Engineering, $80,000, BIG BLUE: Autonomous Flight Demonstration of Mars Airplane Technology.
•Paul Spring, Otolaryngology Surgery, $200,000, Multidrug Resistance in Lung Cancer.
•Joe Springer, Anatomy and Neurobiology, $318,642, COX-2 Pathophysiology in Spinal Cord Injury.
•Patrick Sullivan, Spinal Cord and Brain Injury Research Center, $304,192, Mitochondrial Uncoupling as a Therapeutic Target in TBI.
•John Thelin, Ed Soc and Phi Studies, $4,196, The Kentucky Campus: Colleges, Culture and Community in the Commonwealth.
•Bruce Walcott, Electrical and Computer Engineering, $5,000, Student Technology Leadership Program.

For a complete weekly listing of new research accounts at the University of Kentucky, visit www.rgs.uky.edu/researchreports.html.